(VCNX) |
| 0 (0%) 07-16 12:31 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 20.00 |
| Resistance 1: | 16.48 |
| Pivot price: | 13.96 |
| Support 1: | 10.78 |
| Support 2: | 8.97 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 14 Jul 2026
MSN Money - MSN
Wed, 08 Jul 2026
Vaccinex to Present New Biomarker Data From SIGNAL-AD Study Supporting Expanded Phase 2b Trial of Pepinemab in Early Alzheimer’s Disease - Quiver Quantitative
Wed, 08 Jul 2026
Vaccinex to show new Alzheimer’s biomarker data in London - Stock Titan
Sat, 04 Jul 2026
If You Invested $1,000 in Vaccinex Inc (VCNX) - Stock Titan
Mon, 10 Mar 2025
Vaccinex plans Nasdaq exit as Alzheimer market pressure grows - Pharmaceutical Technology
Thu, 19 Dec 2024
VCNX Stock Price and Chart — OTC:VCNX - TradingView
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
